Evelo Biosciences Inc (EVLO): I revise my estimates: this can do $...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Evelo Biosciences Inc (EVLO)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	1004
Posts	43206
Boards Moderated	0
Alias Born	03/17/2014

Re: None

Friday, 07/21/2023 9:27:53 AM

Friday, July 21, 2023 9:27:53 AM

I revise my estimates:

this can do $15 to $17 today.

$12.5 million bet on this stock is enough to convince me.

Evelo Biosciences

The Trade: Evelo Biosciences, Inc. (NASDAQ: EVLO) 10% owner Noubar Afeyan acquired a total of 5,411,255 shares an average price of $2.31. To acquire these shares, it cost around $12.5 million.
What’s Happening: Evelo Biosciences recently announced a $25.5 million private placement.
What Evelo Biosciences Does: Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent EVLO News

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/26/2024 10:30:25 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 01/26/2024 10:29:48 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/26/2024 10:27:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 10:26:57 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/12/2023 12:43:35 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/12/2023 12:42:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 11:04:28 AM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/01/2023 12:11:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 11:44:05 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:06:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 01:32:53 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 01:32:28 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 01:31:37 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:12:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:11:35 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:11:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 09:24:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 11:05:54 AM
Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis • GlobeNewswire Inc. • 10/17/2023 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/14/2023 12:55:17 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/14/2023 12:55:07 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/14/2023 12:54:53 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/21/2023 09:25:42 PM

More EVLO News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow